PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSTAP* 3 leuprorelin acetate depot injection mg

Similar documents
MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

Testosterone propionate, phenylpropionate, isocaproate and decanoate. Please read this leaflet carefully before you start using SUSTANON 250.

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

Now that your Doctor has prescribed Livial for you

2 What you need to know before you have Ampiclox

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

Breast Cancer. Breast Cancer Page 1

Patient information. Goserelin Zoladex Breast Services Directorate PIF 1005 V3

There is no information on the use of this medicine in those below 12 years of age.

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

N HUMAN Novo Nordisk Patient Information for Novolin N

Restandol Testocaps, 40mg CAPSULES, SOFT Testosterone undecanoate

MEDICATION GUIDE STELARA

Humulin (HU-mu-lin) R

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

injections injections injections injections injections injection injections injections injections tions njections injections injections injections

Teriflunomide (Aubagio) 14mg once daily tablet

IMPORTANT: PLEASE READ

There is a risk of renal impairment in dehydrated children and adolescents.

There is no information on the use of this medicine in those below 12 years of age.

TC: Docetaxel and Cyclophosphamide

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

Temozolomide (oral) with concurrent radiotherapy to the brain

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Prostap SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe (leuprorelin acetate)

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Medication Guide Korlym (KOR-lim) (mifepristone) tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tostran 2% Gel Testosterone

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection

TCH: Docetaxel, Carboplatin and Trastuzumab

MEDICATION GUIDE. TOPAMAX (TOE-PA-MAX) (topiramate) Tablets and Sprinkle Capsules

Presenting the SUTENT Patient Call Center.

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Gemcitabine and Cisplatin

Early Access to Medicines Scheme Treatment protocol Information for patients

MEDICATION GUIDE. SORIATANE (sor-rye-uh-tane) (acitretin) Capsules

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

MEDICATION GUIDE. (topiramate) Tablets. Sprinkle Capsules

Paclitaxel and Carboplatin

Package Leaflet: Information for the user

1 What Anapen is and what it is used for?

SYNACTHEN i.m./i.v. tetracosactide hexaacetate

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

Galvumet Vildagliptin/Metformin hydrochloride Consumer Medicine Information

Medication Guide EQUETRO (ē-kwĕ-trō) (carbamazepine) Extended-Release Capsules

Intravenous Methyl Prednisolone in Multiple Sclerosis

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

For the Patient: Dasatinib Other names: SPRYCEL

MS Treatments Aubagio TM

UBISTESIN 1:200,000 and UBISTESIN FORTE 1:100,000

MEDICATION GUIDE REBIF interferon beta-1a Injection for subcutaneous use

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

implant contraceptiv contraceptive contraceptive raceptiv contraceptive implant contraceptive contraceptive ontraceptive implant ontraceptive im

1. LAMICTAL may cause a serious skin rash that may cause you to be hospitalized or even cause death.

FDA-Approved Patient Labeling IMPLANON (etonogestrel implant) Subdermal Use

Information for patients receiving short-term hormone treatment and radiotherapy for prostate cancer

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

WOMENCARE A Healthy Woman is a Powerful Woman (407) Birth Control Pills

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid

Patient Information Once Weekly FOSAMAX (FOSS-ah-max) (alendronate sodium) Tablets and Oral Solution

AXIRON (AXE-e-RON) CIII

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

Testosterone & Testosterone Replacement Therapy

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

MEDICAL HISTORY AND SCREENING FORM

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Patient Medication Guide Brochure

Medication Guide Rebif (Re-bif) Interferon beta-1a (in-ter-feer-on beta-one-â)

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and

1. What Xylocaine with adrenaline is and what it is used for

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT

Intestinal Permeability Leaky Gut Syndrome Protocol Dr. Kurt Woeller, D.O.

Medication Guide Enbrel (en-brel) (etanercept)

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

MEDICATION GUIDE Trokendi XR (tro-ken-dee eks ahr) (topiramate) Extended-release Capsules

FAQs about Warfarin (brand name Coumadin )

Medication Guide BETASERON (bay-ta-seer-on)

Leflunomide Leflunomide

Hull & East Riding Prescribing Committee

Before you use Enbrel. When you must not use it

AUBAGIO Conversation Starter

Share the important information in this Medication Guide with members of your household.

IMIGRAN injection is also used for treatment of cluster headache. Before you use your IMIGRAN injection. When you must not use it

Trileptal (Oxcarbazepine)

Client Information for Informed Consent TESTOSTERONE FOR TRANSGENDER PATIENTS

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

MEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

WHAT TO EXPECT FROM YOUR TREATMENT. Please see accompanying full Prescribing Information and Important Safety Information on page 14.

For the Patient: Paclitaxel injection Other names: TAXOL

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

General Internal Medicine Clinic New Patient Questionnaire

Why is Cerazette used? To prevent pregnancy.

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER PROSTAP* 3 leuprorelin acetate depot injection 11.25 mg Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What PROSTAP 3 is and what it is used for 2. Before having this medicine 3. How PROSTAP 3 is given 4. Possible side effects 5. How to store PROSTAP 3 6. Further information 1. WHAT PROSTAP 3 IS AND WHAT IT IS USED FOR PROSTAP 3 is a prolonged release powder for use in an injection. The active ingredient in PROSTAP 3 is Leuprorelin. Leuprorelin is a synthetic hormone, which can be used to reduce levels of testosterone and estrogen circulating in the body. PROSTAP 3 is used to treat prostate cancer in men and endometriosis in women. 2. BEFORE HAVING THIS MEDICINE PROSTAP 3 is not recommended for use in children under the age of 18 years. Do not take PROSTAP 3: If you have had an allergic reaction to leuprorelin acetate (PROSTAP SR or PROSTAP 3) in the past. If you are pregnant, planning to become pregnant or are breastfeeding. If you have unusual vaginal bleeding which you have not discussed with your doctor. Take special care with PROSTAP 3: Both men and women: If you are diabetic. PROSTAP 3 can aggravate existing diabetes therefore diabetes patients may need more frequent monitoring of the blood glucose levels. If you are at an increased risk of thinning of the bones (osteoporosis) you should tell your doctor before taking PROSTAP 3. Risk factors include: o If you or any of your close family have thinning of the bones. o If you drink excessive amounts of alcohol, and/or smoke heavily. - 1 -

o If you take drugs for epilepsy or have taken steroids such as hydrocortisone or prednisolone for a long time. If you are a woman with submucous fibroids (benign tumours in the muscle underneath the lining of the womb). PROSTAP 3 can cause severe bleeding when the fibroids breakdown. Contact your doctor immediately if you experience severe or unusual bleeding or pain. If you are a woman and continue to have periods (menstruate) after starting treatment with PROSTAP 3 you should tell your doctor. If you are a woman of child-bearing age, you should use non hormonal contraception, whilst receiving PROSTAP 3. Although PROSTAP 3 causes periods to stop, it is not itself a contraceptive. If you are unsure about this talk to your doctor. Men only: If you are a man with urinary obstruction or spinal cord compression. Your doctor will supervise you closely for the first few weeks of treatment. If you are a man with prostate cancer, and have had injections of a synthetic hormone in the past that has not worked, or you have had an operation to remove your testicles. Taking other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breastfeeding You should not take PROSTAP 3 if you are pregnant, planning to become pregnant or are breastfeeding. Driving and using machines Do not drive or operate machinery if you experience drowsiness, dizziness or visual disturbances whilst being treated with PROSTAP 3. 3. HOW PROSTAP 3 IS GIVEN The doctor or nurse will give you an injection of PROSTAP 3. The injection will normally be given in your arm, thigh or abdomen. The injection site should be varied at regular intervals. You will normally be given an injection once every 3 months. If you have endometriosis you will be given an injection of PROSTAP 3 for a period of 6 months only and treatment will be initiated during the first five days of the menstrual cycle. If you miss an injection As soon as you realise you have missed an injection, contact your doctor who will be able to give you your next injection. If a PROSTAP 3 injection is missed, breakthrough bleeding or ovulation may occur with the potential for conception. If you think you may be pregnant you should stop using PROSTAP 3 and contact your doctor immediately. 4. POSSIBLE SIDE EFFECTS - 2 -

As with all medicines, as well as helping with your illness, PROSTAP 3 can cause unwanted effects (side effects). Contact your doctor immediately or go to hospital: If you develop a severe rash, itching or shortness of breath or difficulty breathing. These could be symptoms of a severe allergic reaction. Tell your doctor: If you get a severe headache which does not get better when you take painkillers. If you suffer from any unexplained bruising or bleeding or feel generally unwell whilst taking PROSTAP 3. Although rare, these could be symptoms of changes in the number of red or white blood cells. If any of the following side effects get serious, or if you notice any side effects not listed in this leaflet, speak to your doctor or pharmacist: Both men and women: PROSTAP 3 can sometimes cause swelling in your ankles, tiredness, nausea or headaches. The treatment may cause pain in the joints, fever or chills, dizziness, vomiting, loss of appetite, diarrhoea, pounding heartbeats, tingling in the hands or feet, muscle aching or weakness, depression, altered vision, changes in weight, jaundice, abnormalities in liver function, thinning of bones, increase in blood pressure, or difficulty sleeping. Sometimes PROSTAP 3 causes redness or discomfort at the place where the injection is given. If you suffer from depression, this may become worse when receiving PROSTAP 3. Blood sugar levels may be altered during treatment with PROSTAP 3, which may affect control in diabetic patients and require more frequent monitoring. If you have a blood test your doctor may notice a change in blood lipid (cholesterol) levels or in values for tests on how the liver is working. These changes do not usually cause any symptoms. If you have an existing pituitary lesion, there may be an increased risk of local bleeding or loss of blood supply. You may experience symptoms such as headache or visual impairment. Men only: When men with prostate cancer first start treatment with PROSTAP 3, levels of testosterone can increase and in some people this may cause a temporary increase in local pain. In some cases, to prevent this from happening, your doctor may give you another type of drug such as cyproterone acetate or flutamide before and just after your first PROSTAP 3 injection. If you do get worsening pain, weakness or loss of feeling in your legs or difficulty passing urine, contact your doctor immediately. PROSTAP 3 can cause a loss of interest in sexual intercourse, hot flushes and occasionally it may cause testicular atrophy (you may notice a reduction in the size of your testicles), or swelling of the breasts. In women PROSTAP 3 may cause hot flushes, vaginal dryness or mood changes including depression. It may cause a change in breast size or breast tenderness and can occasionally cause hair loss. As can happen naturally when women reach the menopause, PROSTAP 3 can cause a small amount of bone thinning. 5. HOW TO STORE PROSTAP 3 Do not store above 25 C. - 3 -

Store in the original container in order to protect from light. Do not use this medicine after the date stated on the packaging. If the pack has been opened or damaged, return it to your pharmacist. 6. FURTHER INFORMATION What PROSTAP 3 contains: The active ingredient in PROSTAP 3 Powder is leuprorelin acetate. The other ingredients in PROSTAP 3 are: poly (D, L-lactic acid), which controls the release of the active ingredient into the body, and mannitol. The Sterile Vehicle contains carmellose sodium, mannitol, polysorbate 80 and Water for Injections. What PROSTAP 3 looks like and contents of the pack: Each pack contains a vial of PROSTAP 3 Powder containing 11.25 mg of active ingredient and a separate syringe containing 2ml of Sterile Vehicle. The Sterile Vehicle is a clear liquid, which is mixed with the PROSTAP 3 Powder before injection. Product Licence Holder and Manufacturer The licence holder is: Takeda UK Limited Takeda House Mercury Park Wooburn Green High Wycombe Bucks. HP10 0HH UK PROSTAP 3 is made by: Wyeth Laboratories New Lane Havant Hants, PO9 2NG UK The Sterile Vehicle is made by: Solvay Pharmaceuticals BV Veenweg 12 8121 AA OLST Netherlands This leaflet does not contain the complete information about your medicine. If you have any questions or you are not sure about anything you should ask your doctor or pharmacist who can give you more information. The information in this leaflet applies only to PROSTAP 3. This leaflet was last approved in 06/2010 * Registered Trademark of Takeda - 4 -

[Takeda logo] This leaflet can be made available in large print, audio or Braille on request. Contact 0800 198 5000 to request this, quoting the following number: 16189/0009. - 5 -